Woodford favourite AstraZeneca raises dividend but profits fall

clock

AstraZeneca, a stalwart of many income portfolios including Neil Woodford's, has said it will raise its dividend by 10% despite sounding an earnings warning for 2012.

The pharmaceutical giant reported pre-tax profits fell in Q4 to $2.05bn compared with $2.28bn in 2010. It also announced it is cutting a further 7,300 jobs and expects earnings to fall this year as...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

All the latest news, analysis and content about the Covid-19 outbreak

Coronavirus Blog: World Health Organisation says travel bans 'not effective'

Latest news and reaction

Investment Week
clock 20 January 2022 • 1 min read
Partner Insight: Three trends likely to transform our global economy

Partner Insight: Three trends likely to transform our global economy

PIMCO’s most recent Secular Forum flagged key drivers of change, as Joachim Fels, Andrew Balls, and Daniel J. Ivascyn report

PIMCO
clock 18 January 2022 • 4 min read
AVI calls for investigation into Third Point governance

AVI calls for appointment of new director to Third Point board

Dispute ongoing

clock 18 January 2022 • 2 min read
Trustpilot